Clinical Trials Directory

Trials / Unknown

UnknownNCT04225481

Evaluation of Enhanced Therapeutic Effect of Adipose Stromal Vascular Fraction Added With Human Platelet Lysate in Treatment of Osteoarthritis

Status
Unknown
Phase
Study type
Observational
Enrollment
27 (estimated)
Sponsor
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

Osteoarthritis (OA) is a highly progressive and debilitating joint disease. Recently, it was demonstrated the existence of an important link between OA inflammation and progression of structural changes. Therapy with intra-articular injection of stromal vascular fraction (SVF) holds great promises and its efficacy could be further augmented with the addition of biological adjuvants. In the present project, we aim at demonstrating that human platelet lysate (HPL) increases the intrinsic beneficial properties of SVF on cartilage regeneration and joint environment. Moreover, we want to verify if SVF-conditioned medium (CM) obtained from SVF primed with HPL yields comparable or superior outcomes than whole SVF.

Conditions

Interventions

TypeNameDescription
OTHERisolation of waste material and culturing with different supplement culture mediaisolation of waste material and culturing with different supplement culture media

Timeline

Start date
2020-01-01
Primary completion
2021-07-01
Completion
2022-07-01
First posted
2020-01-13
Last updated
2020-01-13

Source: ClinicalTrials.gov record NCT04225481. Inclusion in this directory is not an endorsement.